IDEXX Laboratories Inc Cash Flow Conversion Efficiency
IDEXX Laboratories Inc cash flow conversion efficiency. Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) has a cash flow conversion efficiency ratio of 0.215x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($347.16 Million) by net assets ($1.61 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of IDEXX Laboratories Inc (1991–2025)
Cash flow conversion efficiency of IDEXX Laboratories Inc from 1991 to 2025. This chart illustrates how IDEXX Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of IDEXX Laboratories Inc for real-time trading data and today's change.
IDEXX Laboratories Inc Cash Flow Conversion Ratio Explained
IDEXX Laboratories Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
IDEXX Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IDEXX Laboratories Inc ranked by their cash flow conversion efficiency. Also see IDXX stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Telstra Group Ltd
AU:TLS
|
0.206x |
|
Block, Inc
NYSE:XYZ
|
0.045x |
|
Ferrovial SE
NASDAQ:FER
|
0.106x |
|
Live Nation Entertainment Inc
NYSE:LYV
|
0.230x |
|
Sun Life Financial Inc.
TO:SLF
|
0.047x |
|
Goodman Group
AU:GMG
|
0.053x |
|
Itaú Unibanco Holding S.A
F:BVXB
|
-0.202x |
|
Ameriprise Financial Inc
NYSE:AMP
|
0.074x |
Annual Cash Flow Conversion Efficiency for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of IDEXX Laboratories Inc from 1991 to 2025. Review IDEXX Laboratories Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.61 Billion | $1.18 Billion | 0.734x | +26.01% |
| 2024-12-31 | $1.60 Billion | $929.00 Million | 0.582x | -4.64% |
| 2023-12-31 | $1.48 Billion | $906.51 Million | 0.611x | -31.54% |
| 2022-12-31 | $608.74 Million | $542.98 Million | 0.892x | -18.54% |
| 2021-12-31 | $689.99 Million | $755.55 Million | 1.095x | +6.92% |
| 2020-12-31 | $632.79 Million | $648.06 Million | 1.024x | -60.34% |
| 2019-12-31 | $177.82 Million | $459.16 Million | 2.582x | +105.96% |
| 2018-12-31 | $-9.23 Million | $400.08 Million | -43.332x | -525.03% |
| 2017-12-31 | $-53.84 Million | $373.28 Million | -6.933x | -124.23% |
| 2016-12-31 | $-108.21 Million | $334.57 Million | -3.092x | -20.03% |
| 2015-12-31 | $-84.00 Million | $216.36 Million | -2.576x | -228.43% |
| 2014-12-31 | $117.59 Million | $235.85 Million | 2.006x | +322.52% |
| 2013-12-31 | $518.21 Million | $246.00 Million | 0.475x | +31.16% |
| 2012-12-31 | $636.26 Million | $230.28 Million | 0.362x | -11.51% |
| 2011-12-31 | $539.59 Million | $220.70 Million | 0.409x | +31.34% |
| 2010-12-31 | $574.28 Million | $178.83 Million | 0.311x | -7.76% |
| 2009-12-31 | $514.58 Million | $173.72 Million | 0.338x | +3.20% |
| 2008-12-31 | $438.19 Million | $143.34 Million | 0.327x | +6.11% |
| 2007-12-31 | $438.32 Million | $135.12 Million | 0.308x | +15.05% |
| 2006-12-31 | $409.86 Million | $109.83 Million | 0.268x | -15.09% |
| 2005-12-31 | $369.31 Million | $116.55 Million | 0.316x | +31.58% |
| 2004-12-31 | $397.66 Million | $95.38 Million | 0.240x | -15.39% |
| 2003-12-31 | $413.29 Million | $117.16 Million | 0.283x | -6.39% |
| 2002-12-31 | $340.97 Million | $103.25 Million | 0.303x | +97.07% |
| 2001-12-31 | $301.73 Million | $46.36 Million | 0.154x | +42.42% |
| 2000-12-31 | $261.75 Million | $28.24 Million | 0.108x | -41.69% |
| 1999-12-31 | $284.30 Million | $52.60 Million | 0.185x | +23.53% |
| 1998-12-31 | $307.80 Million | $46.10 Million | 0.150x | +235.82% |
| 1997-12-31 | $302.70 Million | $13.50 Million | 0.045x | +79.90% |
| 1996-12-31 | $322.70 Million | $8.00 Million | 0.025x | +1.75% |
| 1995-12-31 | $279.10 Million | $6.80 Million | 0.024x | -83.57% |
| 1994-12-31 | $99.80 Million | $14.80 Million | 0.148x | +67.54% |
| 1993-12-31 | $83.60 Million | $7.40 Million | 0.089x | +6331.58% |
| 1992-12-31 | $70.40 Million | $-100.00K | -0.001x | -101.18% |
| 1991-12-31 | $31.50 Million | $3.80 Million | 0.121x | -- |
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more